These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 658476
21. Liver hamartomas in patients on oral contraceptives. O'Sullivan JP, Wilding RP. Br Med J; 1974 Jul 06; 3(5922):7-10. PubMed ID: 4835461 [Abstract] [Full Text] [Related]
22. Massive intestinal infarction in young women: complication of use of oral contraceptives? Koh KS, Danzinger RG. Can Med Assoc J; 1977 Mar 05; 116(5):513-5. PubMed ID: 837318 [Abstract] [Full Text] [Related]
23. [Patients treated for gynecologic cancer after use of oral contraceptives and IUD]. Szegvári M, Altmayer P. Orv Hetil; 1979 Apr 01; 120(13):756-8. PubMed ID: 424201 [No Abstract] [Full Text] [Related]
24. Effects of different systemic contraceptives on blood fibrinolysis. Brakman P, Sobrero AJ, Astrup T. Am J Obstet Gynecol; 1970 Jan 15; 106(2):187-92. PubMed ID: 5410044 [No Abstract] [Full Text] [Related]
25. Letter: Multiple hepatic adenomas associated with an oral contraceptive. Mdel DG, Fox JA, Jones RW. Lancet; 1975 Apr 12; 1(7911):865. PubMed ID: 48099 [No Abstract] [Full Text] [Related]
26. [Oral contraceptives and cell division]. Sebaoun M, Fournier M, Netter A. Sem Hop; 1968 Nov 08; 44(46):2817-8. PubMed ID: 4311292 [No Abstract] [Full Text] [Related]
27. Veno-occlusive disease of the liver associated with oral contraceptives: case report and review of literature. Alpert LI. Hum Pathol; 1976 Nov 08; 7(6):709-18. PubMed ID: 992650 [Abstract] [Full Text] [Related]
28. [Rupture of hepatic adenoma and oral contraceptives]. Espinoza A, Madrazo L, González J. Prensa Med Mex; 1978 Nov 08; 43(1-2):35-6. PubMed ID: 704533 [Abstract] [Full Text] [Related]
29. Effect of oral contraceptives on acne. Barranco VP, Jones DD. South Med J; 1974 Jun 08; 67(6):703-6. PubMed ID: 4275275 [No Abstract] [Full Text] [Related]
30. Intravenous glucose tolerance after 18 months on progestogen or combination-type oral contraceptive. Goldman JA. Isr J Med Sci; 1978 Mar 08; 14(3):324-7. PubMed ID: 640815 [Abstract] [Full Text] [Related]
31. Benign hepatic tumors secondary to oral contraceptives. Malt S, Shieber W. Mo Med; 1976 Oct 08; 73(10):561-4. PubMed ID: 1012256 [No Abstract] [Full Text] [Related]
33. [Hepatic adenomas and oral contraceptives. Report of two cases and review of the literature (author's transl)]. Sabriá Leal M, Mateu Ratera M, Canals Cadafalch J, Blanch Mortes MD, Munuera Gifre E. Med Clin (Barc); 1979 Oct 10; 73(6):234-8. PubMed ID: 547127 [Abstract] [Full Text] [Related]
35. [Thrombelastography and oral contraceptives]. Delacrétaz-Dubugnon F. Schweiz Med Wochenschr; 1972 Jan 15; 102(2):48-52. PubMed ID: 4644685 [No Abstract] [Full Text] [Related]
36. Mood and behavioural changes with progestational agents. Kane FJ, Daly RJ, Ewing JA, Keeler MH. Br J Psychiatry; 1967 Mar 15; 113(496):265-8. PubMed ID: 6029624 [No Abstract] [Full Text] [Related]
37. [4 cases of hyperplastic gingivitis during estroprogestational contraception]. Muller M, Aloi JC, Namur E. Bull Fed Soc Gynecol Obstet Lang Fr; 1969 Mar 15; 21(3):329-31. PubMed ID: 5400375 [No Abstract] [Full Text] [Related]
38. Colour vision and the 'pill'. Marre M, Neubauer O, Nemetz U. Mod Probl Ophthalmol; 1974 Mar 15; 13(0):345-8. PubMed ID: 4140468 [No Abstract] [Full Text] [Related]